Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Effects of Ambulation Training Utilizing an Exoskeleton Robot on Subjects With Spinal Cord Injury

5 januari 2018 uppdaterad av: Nai-Hsin Meng, China Medical University Hospital

Evaluation of the Physiological and Psychological Effects of Ambulation Training Utilizing an Exoskeleton Robot on Subjects With Spinal Cord Injury

The present study aims to investigate the effects of ReWalk exoskeleton robot training on various physiological and psychological parameters among subjects with spinal cord injury, including body composition and bone mineral mass, balance ability, bowel and bladder symptoms, severity of pain, psychological well-being, and quality of life. Ten patients with paraplegia caused by spinal cord injury will be recruited from the out-patient clinic of Department of Physical Medicine and Rehabilitation at the China Medical University hospital. All participants will undergo dual X-ray absorptiometry to evaluate the baseline bone mineral density. Eligible participants will then take ReWalk training sessions comprises of 3 x 1-hour sessions per week for 40 sessions. A comprehensive battery of outcome measures, including body composition and bone mineral mass, balance ability, bowel and bladder symptoms, severity of pain, psychological well-being, and quality of life, will be utilized for comparison after 40 sessions of ReWalk ambulation training.

Studieöversikt

Status

Okänd

Betingelser

Detaljerad beskrivning

The loss of upright mobility has a profound effect on the health and quality of life for individuals with a spinal cord injury (SCI). The ReWalk exoskeleton is an FDA-cleared, wearable, computer-controlled exoskeleton robot that enables subjects with SCI to stand and walk using crutches to keep balance. China Medical University Hospital is the second hospital in Taiwan to acquire this relatively new rehabilitation robot. ReWalk exoskeleton not only helps the patients with paraplegia regain their ability to walk, previous studies also suggest that restoration of upright mobility may help mitigate the physical and psychological decline routinely experienced by individuals with SCI.

The present study aims to investigate the effects of ReWalk exoskeleton robot training on various physiological and psychological parameters among subjects with spinal cord injury, including body composition and bone mineral mass, balance ability, bowel and bladder symptoms, severity of pain, psychological well-being, and quality of life. Ten patients with paraplegia caused by spinal cord injury will be recruited from the out-patient clinic of Department of Physical Medicine and Rehabilitation at the China Medical University hospital. All participants will undergo dual X-ray absorptiometry to evaluate the baseline bone mineral density. Eligible participants will then take ReWalk training sessions comprises of 3 x 1-hour sessions per week for 40 sessions. The first 20 or so hours of training sessions focus on basic ReWalk skills, and the following training sessions focus on advanced ReWalk skills. A comprehensive battery of outcome measures, including body composition and bone mineral mass, balance ability, bowel and bladder symptoms, severity of pain, psychological well-being, and quality of life, will be utilized to obtain an in-depth overview and comparison of the treatment efficacy after 40 sessions of ReWalk ambulation training. The measures include: muscle strength measurements, Berg Balance Scale, modified Functional Reach Test, 10-Meters Walking Test, Timed Up and Go test, the Short Form-36 and Spinal Cord Injury-Quality Of Life questionnaires for health-related quality of life measurement. Dual X-ray absorptiometry will be used to measure the bone mineral density of the lumbar spine, the proximal femoral region and the distal forearms. It will also be used to estimate fat mass and lean body mass of the participants. All the outcome assessments, except for the Timed Up and Go and the 10-Metersr Walking Test, will be performed prior to the first training session and again at the end of the ReWalk ambulation training sessions. Descriptive data will be provided for all demographic parameters and with a mix-design ANOVA analysis employed to compare pre- and post-training conditions for all repeated outcome measures.

Studietyp

Interventionell

Inskrivning (Förväntat)

10

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

      • Taichung City, Taiwan, 404
        • Rekrytering
        • China Medical University Hospial
        • Huvudutredare:
          • Nai-Hsin Meng, M.D.
        • Kontakt:
        • Underutredare:
          • Li-Wei Chou, M.D. Ph.D.
        • Underutredare:
          • Pei-Yu Yang, M.D.

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

20 år till 65 år (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  1. Between the age of 20-65 years old;
  2. Have paraplegia resulting from thoracic or lumbar spinal cord injury.
  3. At least 6 months after onset of the spinal cord injury
  4. Well motivated and willing to participate 40 hours of ReWalk ambulation training sessions.

Exclusion Criteria:

  1. Have spinal cord injury neurologic level above T4
  2. Height greater than 190 cm or lower than160 cm
  3. Weight greater than 100 kg
  4. Have osteoporosis (T-score < -2.5)
  5. Deep vein thrombosis
  6. Severe orthostatic hypotension precluding standing and walking training
  7. Pregnancy
  8. Cognitive impairments that would impact on the safe participation in the study
  9. Severe spasticity of lower limbs (Modified Ashworth Scale >3)
  10. Contracture of the ankle, or a knee flexion contracture greater than 10 degrees
  11. Musculoskeletal conditions that affected gait capacity
  12. Co-existence of other neurological diseases

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Stödjande vård
  • Tilldelning: N/A
  • Interventionsmodell: Enskild gruppuppgift
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Exoskeleton robot ambulation training
Ambulation training utilizing an exoskeleton robot
Participants undergo 40 hours of ambulation training utilizing an exosksleton robot within 3 months.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
bone mineral density
Tidsram: Change from baseline at 1 week after completion of 40 hours of ambulation training
bone mineral density of the lumbar spine, the proximal femoral region and the distal forearms, measured by dual X-ray absorptiometry
Change from baseline at 1 week after completion of 40 hours of ambulation training

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
SF-36
Tidsram: change from baseline at 1 week after completion of 40 hours of ambulation training
SF-36 contains 36 items comprising eight subscales: physical functioning (PF), role limitations due to physical problems (RP), bodily pain, general health perceptions (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH). All subscales are transformed into a 0-100 scale, with 100 indicating the best status.
change from baseline at 1 week after completion of 40 hours of ambulation training
Spinal Cord Injury-Quality of Life measurement system
Tidsram: change from baseline at 1 week after completion of 40 hours of ambulation training

The SCI-QOL consists of 19 item banks, including the SCI-Functional Index banks, and 3 fixed-length scales measuring physical, emotional, and social aspects of health-related QOL (HRQOL). A description of the score range (and which values are considered to be a better or worse outcome) is not included because it greatly exceeds the 999-character limitation allowed in the box of "descrpition"

Emotional Health Domain:

Positive Affect & Well-Being, Depression, Anxiety, Stigma, Resilience, Grief/Loss, Self-Esteem and Psychological Trauma

Physical-Medical Health Domain:

Skin/Pressure Ulcers Scale, Bladder Complications Scale, Bladder Management Difficulties, Bowel Management Difficulties, Pain Interference and Pain Behavior Scale.

Social Participation Domain:

Ability to Participate in Social Roles and Activities, Satisfaction with Social Roles and Activities, Independence.

SCI-Functional Index banks: Basic Mobility, Ambulation, Fine Motor, Self-Care and Wheelchair activities.

change from baseline at 1 week after completion of 40 hours of ambulation training
fat mass
Tidsram: change from baseline at 1 week after completion of ambulation training
fat mass measured by dual X-ray absorptiometry
change from baseline at 1 week after completion of ambulation training
lean body mass
Tidsram: change from baseline at 1 week after completion of 40 hours of ambulation training
lean body mass measured by dual X-ray absorptiometry
change from baseline at 1 week after completion of 40 hours of ambulation training
Berg Balance Scale
Tidsram: change from baseline at 1 week after completion of 40 hours of ambulation training
measuring sitting balance ability; minimum score: 0, maximu score 56; higher values represent a better outcome
change from baseline at 1 week after completion of 40 hours of ambulation training

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Nai-Hsin Meng, M.D., China Medical University, China Medical University Hospital

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

23 november 2017

Primärt slutförande (Förväntat)

31 oktober 2019

Avslutad studie (Förväntat)

31 december 2019

Studieregistreringsdatum

Först inskickad

7 november 2017

Först inskickad som uppfyllde QC-kriterierna

8 november 2017

Första postat (Faktisk)

14 november 2017

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

8 januari 2018

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

5 januari 2018

Senast verifierad

1 januari 2018

Mer information

Termer relaterade till denna studie

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Ja

produkt tillverkad i och exporterad från U.S.A.

Ja

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Kliniska prövningar på Ryggmärgsskador

Prenumerera